Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis.
Robella M, Tonello M, Berchialla P, Sciannameo V, Ilari Civit AM, Sommariva A, Sassaroli C, Di Giorgio A, Gelmini R, Ghirardi V, Roviello F, Carboni F, Lippolis PV, Kusamura S, Vaira M. Robella M, et al. Among authors: ghirardi v. Cancers (Basel). 2023 Jan 17;15(3):570. doi: 10.3390/cancers15030570. Cancers (Basel). 2023. PMID: 36765534 Free PMC article. Review.
Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal Metastases.
Ghirardi V, Fagotti A, Ansaloni L, Valle M, Roviello F, Sorrentino L, Accarpio F, Baiocchi G, Piccini L, De Simone M, Coccolini F, Visaloco M, Bacchetti S, Scambia G, Marrelli D. Ghirardi V, et al. Cancers (Basel). 2023 Jan 7;15(2):407. doi: 10.3390/cancers15020407. Cancers (Basel). 2023. PMID: 36672356 Free PMC article.
Value of pre-existent bacterial colonization in patients with advanced/relapsed ovarian neoplasms undergoing cytoreductive surgery: a multicenter observational study (BONSAI).
Fotopoulou C, Rinne N, Ghirardi V, Cunnea P, Drosou A, Tzovaras D, Giudice MT, Scambia G, Fagotti A. Fotopoulou C, et al. Among authors: ghirardi v. Int J Gynecol Cancer. 2020 Oct;30(10):1562-1568. doi: 10.1136/ijgc-2020-001475. Epub 2020 Aug 18. Int J Gynecol Cancer. 2020. PMID: 32817201
Current and future trials about HIPEC in ovarian cancer.
Ghirardi V, Trozzi R, Scambia G, Fagotti A. Ghirardi V, et al. Bull Cancer. 2024 Mar;111(3):254-260. doi: 10.1016/j.bulcan.2023.01.016. Epub 2023 Feb 28. Bull Cancer. 2024. PMID: 36863924 Review.
Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes.
Ghirardi V, Trozzi R, Scanu FR, Giannarelli D, Santullo F, Costantini B, Naldini A, Panico C, Frassanito L, Scambia G, Fagotti A. Ghirardi V, et al. Ann Surg Oncol. 2024 May;31(5):3350-3360. doi: 10.1245/s10434-024-15042-0. Epub 2024 Feb 27. Ann Surg Oncol. 2024. PMID: 38411761 Free PMC article.
30 results